Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: University of Nottingham

Study finds Parkinson’s disease SLT more effective than one used in NHS

Study finds Parkinson’s disease SLT more effective than one used in NHS
p p Read More

The progressive neurodegenerative condition affects around 153,000 people in the UK

July 16, 2024 Lee Silverman Voice Treatment, neurodegenerative conditions, News, Parkinson's disease, PD-COMM, speech and language therapy, University of Birmingham, University of Nottingham

Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients

Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients
p p Read More

The cardiovascular disease, pulmonary arterial hypertension, affects around 6,500 people in the UK

May 16, 2024 Alan Turing Institute, CVD-Net, digital twin heart models, Imperial College London, News, Pulmonary Arterial Hypertension, University of Nottingham

New heart disease calculator more accurately predicts patients’ risk of CVDs

According to the World Health Organization, CVDs are responsible for an estimated 17.9 million deaths every year

April 24, 2024 cardiovascular diseases, King’s College London, News, QR4, QRISK, University of Nottingham, university of oxford

Study links dementia antipsychotics to higher risks of serious health outcomes

The neurodegenerative condition currently affects more than 944,000 people living in the UK

April 22, 2024 antipsychotics, Dementia, News, University of Dundee, University of Edinburgh, University of Manchester, University of Nottingham

Parkinson’s UK grants funding of up to nearly £450,000 to four new research projects

The globally fast-growing progressive neurological condition affects around 153,000 people in the UK

March 21, 2024 King’s College London, London Metropolitan University, neurological diseases, News, Parkinson's disease, Parkinson’s UK, Robert Gordon University, University of Nottingham
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy